About Debasish Roychowdhury
Debasish Roychowdhury is a director of Rgenta Therapeutics, Inc. The company develops RNA-targeting medicines aimed at diseases that have been historically hard to treat with drugs.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Debasish Roychowdhury in the role, so the role may have started earlier or lasted longer.
Rgenta Therapeutics, Inc. Current
Director
2021 – Present · Woburn, MA
The company develops oral small-molecule drugs that target RNA to treat cancer and neurological diseases that current medicines cannot reach.
Key Colleagues at Startups
The people Debasish Roychowdhury works with at each company, as listed on that company's latest Form D.
Rgenta Therapeutics, Inc. · Form D, Nov 3, 2026
HX
Hualin Xi
Co-founder and CEO, director
YF
Yichao Fan
Director
Julia Kaufman
Director
SZ
Sean Zhang
Director and promoter
CK
Cillian King
Director and promoter
JK
James Kasuboski
Director
Travis Wager
Co-founder, President and CSO
ZW
Zhiping Weng
Director
Jeff Guckert
Director of Finance